• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与含磷脂酰丝氨酸的模型膜结合的凝血因子 VIII 的拓扑结构。

Topology of factor VIII bound to phosphatidylserine-containing model membranes.

作者信息

Purohit Vivek S, Ramani Karthik, Kashi Ramesh S, Durrani Manzer J, Kreiger Timothy J, Balasubramanian Sathyamangalam V

机构信息

The Department of Pharmaceutical Sciences, University at Buffalo, State University of New York, 541 Cooke Hall, Amherst, NY 14260-1200, USA.

出版信息

Biochim Biophys Acta. 2003 Oct 31;1617(1-2):31-8. doi: 10.1016/j.bbamem.2003.08.012.

DOI:10.1016/j.bbamem.2003.08.012
PMID:14637017
Abstract

Factor VIII (FVIII), a plasma glycoprotein, is an essential cofactor in the blood coagulation cascade. It is a multidomain protein, known to bind to phosphatidylserine (PS)-containing membranes. Based on X-ray and electron crystallography data, binding of FVIII to PS-containing membranes has been proposed to occur only via the C2 domain. Based on these models, the molecular topology of membrane-bound FVIII can be envisioned as one in which only a small fraction of the protein interacts with the membrane, whereas the majority of the molecule is exposed to an aqueous milieu. We have investigated the topology of the membrane-bound FVIII using biophysical and biochemical techniques. Circular dichroism (CD) and fluorescence studies indicate no significant changes in the secondary and tertiary structure of FVIII associated with the membranes. Acrylamide quenching studies show that the protein is predominantly present on the surface of the membrane, exposed to the aqueous milieu. The light scattering and electron microscopy studies indicate the absence of vesicle aggregation and fusion. Binding studies with antibodies directed against specific epitopes in the A1, A2 and C2 domains suggest that FVIII binds to the membrane primarily via C2 domain including the specific phospholipid binding epitope (2303-2332) and may involve subtle conformational changes in this epitope region.

摘要

凝血因子VIII(FVIII)是一种血浆糖蛋白,是血液凝固级联反应中必不可少的辅因子。它是一种多结构域蛋白,已知可与含磷脂酰丝氨酸(PS)的膜结合。根据X射线和电子晶体学数据,FVIII与含PS膜的结合被认为仅通过C2结构域发生。基于这些模型,膜结合FVIII的分子拓扑结构可设想为只有一小部分蛋白质与膜相互作用,而分子的大部分暴露于水相环境中。我们使用生物物理和生化技术研究了膜结合FVIII的拓扑结构。圆二色性(CD)和荧光研究表明,与膜相关的FVIII的二级和三级结构没有显著变化。丙烯酰胺猝灭研究表明,该蛋白主要存在于膜表面,暴露于水相环境中。光散射和电子显微镜研究表明不存在囊泡聚集和融合现象。针对A1、A2和C2结构域中特定表位的抗体结合研究表明,FVIII主要通过包含特定磷脂结合表位(2303 - 2332)的C2结构域与膜结合,并且可能涉及该表位区域的细微构象变化。

相似文献

1
Topology of factor VIII bound to phosphatidylserine-containing model membranes.与含磷脂酰丝氨酸的模型膜结合的凝血因子 VIII 的拓扑结构。
Biochim Biophys Acta. 2003 Oct 31;1617(1-2):31-8. doi: 10.1016/j.bbamem.2003.08.012.
2
Lack of recombinant factor VIII B-domain induces phospholipid vesicle aggregation: implications for the immunogenicity of factor VIII.重组因子VIII B结构域的缺失诱导磷脂囊泡聚集:对因子VIII免疫原性的影响。
Haemophilia. 2014 Sep;20(5):723-31. doi: 10.1111/hae.12421. Epub 2014 Apr 21.
3
3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography.膜结合凝血因子VIII的三维结构:在通过电子晶体学获得的三维密度图内对因子VIII异二聚体进行建模。
Blood. 2002 Feb 15;99(4):1215-23. doi: 10.1182/blood.v99.4.1215.
4
Biophysical characterization of blood coagulation factor VIII binding to lipid nanodiscs that mimic activated platelet surfaces.模拟活化血小板表面的脂质纳米盘结合凝血因子VIII的生物物理特性研究
J Thromb Haemost. 2025 Feb;23(2):513-524. doi: 10.1016/j.jtha.2024.11.003. Epub 2024 Nov 15.
5
Antigenicity of putative phospholipid membrane-binding residues in factor VIII.凝血因子VIII中假定的磷脂膜结合残基的抗原性。
Blood. 2001 Jan 1;97(1):169-74. doi: 10.1182/blood.v97.1.169.
6
Factor VIII C1 domain spikes 2092-2093 and 2158-2159 comprise regions that modulate cofactor function and cellular uptake.VIII 因子 C1 结构域的 2092-2093 和 2158-2159 位突刺包含了调节辅助因子功能和细胞摄取的区域。
J Biol Chem. 2013 Oct 11;288(41):29670-9. doi: 10.1074/jbc.M113.473116. Epub 2013 Sep 5.
7
Some factor VIII inhibitor antibodies recognize a common epitope corresponding to C2 domain amino acids 2248 through 2312, which overlap a phospholipid-binding site.一些凝血因子VIII抑制物抗体识别一个与C2结构域氨基酸2248至2312相对应的共同表位,该表位与一个磷脂结合位点重叠。
Blood. 1995 Sep 1;86(5):1811-9.
8
The 1.7 Å X-ray crystal structure of the porcine factor VIII C2 domain and binding analysis to anti-human C2 domain antibodies and phospholipid surfaces.猪源因子VIII C2结构域的1.7埃X射线晶体结构及其与抗人C2结构域抗体和磷脂表面的结合分析。
PLoS One. 2015 Mar 16;10(3):e0122447. doi: 10.1371/journal.pone.0122447. eCollection 2015.
9
Binding of recombinant human coagulation factor VIII to lipid nanotubes.重组人凝血因子VIII与脂质纳米管的结合
FEBS Lett. 2008 May 28;582(12):1657-60. doi: 10.1016/j.febslet.2008.04.018. Epub 2008 Apr 22.
10
Use of surface plasmon resonance for studies of protein-protein and protein-phospholipid membrane interactions. Application to the binding of factor VIII to von Willebrand factor and to phosphatidylserine-containing membranes.表面等离子体共振在蛋白质-蛋白质及蛋白质-磷脂膜相互作用研究中的应用。因子VIII与血管性血友病因子及含磷脂酰丝氨酸膜结合的应用。
J Chromatogr A. 1999 Aug 6;852(1):59-71. doi: 10.1016/s0021-9673(99)00491-4.

引用本文的文献

1
Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model.鞘内注射磷脂酰丝氨酸纳米粒在血友病 A 小鼠模型中诱导针对因子 VIII 的免疫耐受。
Int J Pharm. 2018 Sep 5;548(1):642-648. doi: 10.1016/j.ijpharm.2018.07.018. Epub 2018 Jul 5.
2
Phosphatidylserine Is Not Just a Cleanup Crew but Also a Well-Meaning Teacher.磷脂酰丝氨酸不仅是一个清理团队,也是一个善意的老师。
J Pharm Sci. 2018 Aug;107(8):2048-2054. doi: 10.1016/j.xphs.2018.03.027. Epub 2018 Apr 9.
3
Binding of Factor VIII to Lipid Nanodiscs Increases its Clotting Function in a Mouse Model of Hemophilia A.
在A型血友病小鼠模型中,凝血因子VIII与脂质纳米盘的结合增强了其凝血功能。
J Blood Disord Transfus. 2015 Dec;6(6):325. doi: 10.4172/2155-9864.1000325. Epub 2015 Dec 18.
4
Effect of Biophysical Properties of Phosphatidylserine Particle on Immune Tolerance Induction Toward Factor VIII in a Hemophilia A Mouse Model.磷脂酰丝氨酸颗粒的生物物理性质对甲型血友病小鼠模型中针对凝血因子VIII免疫耐受诱导的影响。
J Pharm Sci. 2016 Oct;105(10):3039-3045. doi: 10.1016/j.xphs.2016.06.008. Epub 2016 Jul 16.
5
PEGylation of a factor VIII-phosphatidylinositol complex: pharmacokinetics and immunogenicity in hemophilia A mice.VIII 因子-磷脂酰肌醇复合物的聚乙二醇化:血友病 A 小鼠的药代动力学和免疫原性。
AAPS J. 2012 Mar;14(1):35-42. doi: 10.1208/s12248-011-9309-2. Epub 2011 Dec 16.
6
Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes.磷脂酰肌醇诱导磷脂酰胆碱模型膜中形成流体相和堆积缺陷。
Chem Phys Lipids. 2012 Jan;165(1):15-22. doi: 10.1016/j.chemphyslip.2011.10.002. Epub 2011 Oct 17.
7
Immunogenicity and pharmacokinetic studies of recombinant factor VIII containing lipid cochleates.脂质体包封重组因子 VIII 的免疫原性和药代动力学研究。
Drug Deliv. 2011 May;18(4):246-54. doi: 10.3109/10717544.2010.536269. Epub 2010 Nov 30.
8
Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function.磷脂酰丝氨酸通过调节树突状细胞功能降低血友病 A 小鼠对人重组因子 VIII 的免疫反应。
Clin Immunol. 2011 Feb;138(2):135-45. doi: 10.1016/j.clim.2010.10.006. Epub 2010 Nov 20.
9
Phosphatidylinositol containing lipidic particles reduces immunogenicity and catabolism of factor VIII in hemophilia a mice.含磷酰肌醇脂质颗粒可降低血友病 A 小鼠模型中因子 VIII 的免疫原性和代谢率。
AAPS J. 2010 Sep;12(3):473-81. doi: 10.1208/s12248-010-9207-z. Epub 2010 Jun 2.
10
Role of glycosylation in conformational stability, activity, macromolecular interaction and immunogenicity of recombinant human factor VIII.糖基化在重组人凝血因子 VIII 的构象稳定性、活性、大分子相互作用及免疫原性中的作用
AAPS J. 2009 Sep;11(3):424-31. doi: 10.1208/s12248-009-9119-y. Epub 2009 Jun 5.